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The Veterans Health Administration is implementing a pragmatic trial research program, called Point of
Care Research (POC-R). The purpose of this telephone survey in which respondents were randomized to
different framing conditions of the purpose of POC-R was to determine the impact of differing frames of
the purpose of POC-R on attitudes towards the program and intentions to participate; and the relative
importance of different beliefs and attitudes in discriminating low vs. high intenders to participate in
POC-R. The survey addressed veterans’ perceptions and attitudes towards POC-R, and their willingness to
participate in a pragmatic trial. Overall, respondents felt positively towards POC-R and intended to
participate. Differing frames of the purpose of POC-R were not associated with either attitudes (towards
the program) or intentions to participate. However, speciﬁc beliefs and attitudes toward POC-R program
were predictive of intentions to participate.
Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The Institute of Medicine (IOM) deﬁnes a Learning Health
System as “one in which progress in science, informatics, and care
culture align to generate new knowledge as an ongoing, natural
by-product of the care experience, and seamlessly reﬁne and
deliver best practices for continuous improvement in health and
health care.” (IOM, 2012). Pragmatic randomized clinical trials
have been proposed as one mechanism to support a Learning
Health System and improve the evidence base of clinical practice.
Pragmatic clinical trials are research studies that are conducted
during the process of care under situations of clinical equipoise (in
which the evidence regarding the risk/beneﬁts of competing
treatments is approximately equal) (Elwyn, Edwards, Kinnersley, &
Grol, 2000; Little et al., 2001) The goal of pragmatic trials is to
ameliorate limitations to the generalizability of research ﬁndings
by using: (1) typical clinical settings, (2) clinical populations that
are representative of the targeted population (as opposed to the
highly selected populations commonly enrolled in clinical trials),
and (3) clinicians who practice in the situations where theaccess article under the CC BY-NC
cal Informatics, University of
2460.
).intervention would be implemented (Chalkidou, Tunis, Whicher,
Fowler, & Zwarenstein, 2012; Thorpe et al., 2009; Zwarenstein
et al., 2008).
The Veterans Healthcare Administration (VA) is considering a
new research program, called Point of Care Research (POC-R),
which is based on the concept of pragmatic trials. The POC-R
program would support research conducted during the process of
care; randomization would be a part of regular clinical care deci-
sions. To the degree that the treatment arms of a study are judged
to have equipoise, speciﬁc POC-R trials may not require consent or
additional oversight.
A pragmatic trial program highlights the tension between two
perspectives of clinical research. In the traditional view, all clinical
research puts patients at risk and therefore they must be protected
through informed consent. In the pragmatic triallist’s view, the fact
that both treatment arms represent accepted practice suggests
that no differential harm is expected. In this latter view, it is
thought to be both practical and ethical to allow lower levels of
oversight and monitoring and to allow modiﬁcation to the usual
informed consent process (Vickers, & Scardino, 2009). This differ-
ence reﬂects the purpose of these different forms of research:
traditional research is intended to develop new knowledge, while
pragmatic trials are intended to compare efﬁcacious interventions
to identify the one that is most efﬁcient and effective across a
range of outcomes.-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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trials to potential participants may be an important predictor of
individuals’ willingness to participate, however this question has
not yet been addressed. In this study, the question we sought to
address is not whether one particular explanation of the purpose
of point of care research would be better or worse than others but
the more general question of whether framing effects would
impact people's attitudes and intentions towards POC research. In
summary of the goals of this study were to determine: (1) whether
differing frames regarding the purpose of POC-R were associated
with attitudes towards the program and intentions to participate;
and (2) the relative importance of different beliefs and attitudes in
discriminating low vs. high intenders to participate in POC-R.
Finally, since consent models are an important implementation
issue in POC-R, our third exploratory aim was to assess the
relationship between individual’s beliefs about POC-R and their
willingness to engage in yearly consent for the program.
Prior work
As part of an internal evaluation of the POC-R program, a series
of focus groups were conducted across 7 VA medical centers with
48 patients (Weir, Butler, Barrus, & Lewis, 2013). Qualitative ana-
lysis of the transcripts from these focus groups found 6 different
thematic areas: (1) concern over the potential burden of partici-
pating, (2) concern over the impact of the program on the provi-
der–patient relationship, (3) the value of the research to the VA;
(4) belief that it would improve care, (5) belief that, as veterans,
they had a personal responsibility or duty to participate in research
that might help other veterans, and (6) concern regarding differing
models of consent. These themes were used for item construction
in the development the survey.
In these focus groups, we found that nearly all patients had
difﬁculty understanding the purpose of POC-R. We explored dif-
ferent explanations and purposes with the focus group partici-
pants in order to maximize their understanding of the program.
Explanations that emphasized how POC-R might improve the
quality of care, reduce costs and improve efﬁciency, and/or lead to
improved scientiﬁc knowledge were all tried with these groups.
However, we were not sure how these different explanations
might impact attitudes and intentions to participate. Given that
prior research has demonstrated that small differences in how
programs or interventions are described may lead to signiﬁcant
impacts on perceptions of value, and on behavioral choice
(Kühberger, 1998), we felt it was necessary to directly test these
differing explanations of the purpose behind POC-R on attitudes or
intentions to participate.Methods
Design
The study was a randomized experiment embedded in a tele-
phone survey. Participants were randomized to one of three
frames describing the purpose of POC-R:
) Improving clinical quality (“The goal of POC-R studies is to
improve the quality of care by determining which options for
care are safe, appropriate and meet performance standards”);
) Reduce costs (“The goal of POC-R studies is to improve the
efﬁciency of healthcare delivery by determining which options
for care are the least costly and the most efﬁcient. In POC-R
studies, the treatment options being compared are both effective,
but vary in terms of the ease and feasibility of implementation”);) Improve science (“The goal of POC-R studies is to enhance
scientiﬁc knowledge by comparing treatments using large
numbers of patients across diverse geographical areas and in a
variety of natural care settings”).
Construction of the survey
The survey items were based on the themes identiﬁed in the
focus groups and were constructed using an adapted Likert format,
scored on a 1–7 scale. Survey items were created to assess indi-
viduals’ general attitude toward POC-R as well as to reﬂect the
speciﬁc attitudes expressed in the focus groups. Finally, items to
capture intentions to participate were created. Piloting of sample
items was conducted with 5 veterans. The telephone survey used
in this study is listed in Appendix 1.
Participants/setting
The study was conducted at HOSPITAL, this center includes a
113-bed hospital and 5 Community based outpatient clinics. The
study was given IRB approval by both the University and VA
Boards.
A sample of 496 English-speaking veterans without dementia
who had been seen in a primary care clinic in the previous 3 years
were selected at random from the VA’s clinical data warehouse
and contacted by phone. Of this initial sample 333 did not respond
to phone messages left asking them to call back regarding a sur-
vey, and 13 refused participation. 150 individuals agreed to parti-
cipate and 141 provided complete answers to all survey questions.
Creation of outcome scales
We created and tested two scales from the raw survey data to
measure our two outcomes of interest: Attitudes towards POC-R
and Intentions to participate in POC-R. Finally, since consent
models are an important aspect of pragmatic trials, we created a
Consent scale to reﬂect participants’ willingness to engage in
blanket consent.
The Attitude scale combined individual’s responses to 3 ques-
tions: (1) “Should POC-R be implemented in the VA” (question 7);
(2) “You think POC-R is – not important/very important” (question
9) and (3) “You believe that the POC-R research program will
improve the quality of care in the VA” – not at all/a great deal
(question 10).
The Intention scale combined individual’s responses to 3 ques-
tions. The ﬁrst question asked the likelihood they would agree to
participate (question 4). The second question asked for the prob-
ability they would participate (question 8); this response was
originally scored as 0–100% and was normalized to 0–7 prior to
calculation of this scale. The third question asked for their will-
ingness to participate in POC-R (question 11).
The Consent scale was the mean of the individuals response to
two questions: “Based on what you know today, would you be
willing to give a blanket consent, (covers all studies) yearly to be
part of any local ongoing POC-R studies?” – very unlikely/very
likely (Question 12), and “If you could consent only once for all
ongoing POC-R studies in your VA for a year, you would be?” – Not
at all willing/willing, (question 18).
Analysis
Several analyses were conducted, using R statistical computing
software for all analyses (The R Project for Statistical Computing,
2012). First, we tested the internal reliability (Cronbach’s alpha) of
the scales for attitudes toward the program, intention to participate
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consent described above.
Second, to determine whether the differing frames of the
purpose of POC-R affected attitudes towards the program or
veterans’ intentions to participate, we created two linear models
for each of the attitudes and intentions scales. In each model we
regressed the scale on framing conditions (modeled as a factor)
while correcting for baseline demographic differences between
groups.
Third, to determine which beliefs would best discriminate
individuals who were high vs. low intenders to participate in POC-
R, we used a cross-validated LASS0 procedure on a logistic model.
In this analysis we ﬁrst created a median split on the intention
scale, this was our dependent variable. We then ran a leave one out
cross validation of a Least Absolute Selection Shrinkage Operator
(LASSO) on the logistic model to select those beliefs that dis-
criminated between high vs. low intenders. The LASSO uses a
shrinkage parameter, lambda, to constrain the values of potential
covariates in a model such that some coefﬁcients are constrained
to be zero and are therefore left out of the model. Model accuracy
was assessed by using the cross validated predictions from the
model in which lambda was within one standard error of the value
of lambda which gave the least squared error. To calculate the
relative importance of beliefs selected, we created a second model
that included only covariates selected by the LASSO and calculated
the 95% conﬁdence interval for the odds ratios for each belief.
Finally we plotted the relationship between individuals’ beliefs
(using only those beliefs signiﬁcant in the ﬁnal model) and their
intention class.
To inform future work we calculated the correlation between
the consent scale and the other beliefs measured. These results are
included in Appendix 2.Table 2
Effect of framing on attitudes and intentions towards POC-R.
Outcome Covariates Coefﬁcient Std. error T-value P-Value
Attitudes Cost frame 0.053 0.29 0.18 0.86
Quality frame 0.001 0.31 0.006 0.99
Age 0.009 0.007 1.1 0.27
Intentions Cost frame 0.25 0.40 0.6 0.53
Quality frame 0.53 0.41 1.3 0.20
Age 0.0004 0.01 0.03 0.97Results
Description of participants
Table 1 presents the age, number of self-reported clinic visits to
the VA and number of self-reported VA hospitalizations for partici-
pants in each condition, and the counts and proportion of individuals
in each condition who had either personally consented to VA
research in the past or knew someone who had. Despite randomi-
zation to condition, Individuals who were randomized to the
“improving the Quality of care” frame were signiﬁcantly older than
individuals in the other two conditions. There were no other sig-
niﬁcant differences between groups in these demographic measures.
Internal reliability of scales
The internal reliability of the Attitude, Intention and Consent
scales were excellent, with Cronbach’s alphas of 0.77 (95% CI 0.63–
0.92), 0.89 (95% CI 0.77–1.01) and 0.88 (95% CI 0.69–1.08)
respectively.Table 1
Demographics of survey respondents.
Science (n¼47) Cost
Age 62.0 (16.5) 60.9
# Clinic visits in the VA in past year 15.4 (27.0) 9.6
# Hospitalizations in the VA in past year 1.6 (7.9) 0.53
Consented to VA research before? 15 (31.9) 10
Know Others who have consented? 11 (23.4) 19
a F statistic.
b Chi-squared.Impact of framing
On average, respondents expressed positive attitudes toward
the POC-R program and moderate intentions to participate: mean
Attitudes scale¼5.4, SD¼1.44, range: 1.0–7.0 and mean Intentions
scale¼5.0, SD¼1.94, range: 0.66–7.0.
After accounting for baseline difference in age between groups,
differing explanations of the purpose of POC-R were not associated
with Attitudes towards the program. Table 2 presents the results of
the two linear models testing this hypothesis.
Logistic regression analysis
Table 3 presents the results of the Least Absolute Square
Selection Operator (LASSO) of the logistic regression. Beliefs that
characterized individuals who are high intenders to participate in
POC-R were: (1) the belief that clinical research is valuable, (2)
willingness to engage in either blanket or yearly consent for the
program, (3) the belief that POC-R will improve the quality of care,
and (4) a belief that participating in a research is a duty. The cross-
validated model accurately classiﬁed 108/141 participants, an
overall accuracy of 76.5%.
Table 4 presents the results of the logistic model with only the
covariates from the LASSO included.Discussion
In this study we examined whether differing frames of the
purpose of the VA’s Point of Care research (POC-R) program were
associated with differences in attitudes toward the program and
willingness to participate. In addition, we examined whether dif-
ferent beliefs about the program would be associated with will-
ingness to participate. We found that framing was not associated
with differences in attitudes or intentions. In contrast, we found
that individuals’ beliefs about POC-R did discriminate individuals
who were low vs. high in intentions to participate. More speciﬁ-
cally, beliefs that clinical research is valuable and that POC-R
would improve the quality of care were positively associated with
intentions to participate. In addition, individuals who were willing
to participate in a yearly or blanket consent for POC-R studies were(n¼49) Quality (n¼45) Test statistic P-valuea
(16.2) 67.9 (13.9) 4.6a 0.03
(12.0) 18.4 (59.8) 1.3a 0.26
(1.0) 0.75 (3.0) 1.1a 0.29
(20.4) 8 (17.8) 2.9b 0.23
(38.7) 14 (31.1) 2.6b 0.27
Table 3
Results of least absolute squares selection operator analysis of beliefs predictive of
low vs. high intentions to participate in POC-R.
Belief Odds ratio
I am willing to engage in a blanket consent for POC-R 1.27
POC-R will improve the quality of care 1.24
Clinical research is valuable 1.14
I would be willing to consent once a year to partici-
pate in POC-R
1.08
Participating in a research is a duty 1.02
It will take effort to participate in POCR 1.00
It will take time to participate in POCR 1.00
Doctor’s control over care will change 1.00
If I participate in POC-R my relationship with my
doctor will change
1.00
Quality of care will change 1.00
POC-R should be in the VA 1.00
Clinical research is important 1.00
It is important to me to be informed of research
results
1.00
It is important to me to consent to every study 1.00
My relationship with my doctor is important to me 1.00
It is Important to me to be compensated for partici-
pating in research
1.00
It is important to me to keep my health record private 1.00
Table 4
Logistic regression model using beliefs selected by LASSO of low vs. high intenders
to participate in POC-R.
Belief Odds ratio
(95% CI)
Std.
error
Z
value
P-
value
Clinical research is valuable 2.46 (1.18–5.95) 0.40 2.23 0.02n
I am willing to engage in a blanket
consent for POC-R
1.39 (1.07–1.85) 0.14 2.44 0.01n
POC-R will improve the quality of
care
1.43 (0.99–2.14) 0.19 1.85 0.06
I would be willing to consent once a
year to participate in POC-R
1.16 (0.86–1.56) 0.15 0.96 0.33
Participating in a research is a duty 1.12 (0.90–1.39) 0.11 1.04 0.29
n Po0.05.
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addressing an important implementation issue.
The results of this study are important for two reasons. First,
since the goal of POC-R is to recruit large, representative samples
of patient populations, knowledge of beliefs that inﬂuence
patients’ willingness to participate should help with developing
recruitment and strategies and materials for the program. These
correlations would be likely to replicate in the non-VA population
as well. Second, our ﬁnding that there was no signiﬁcant differ-
ences in attitudes towards the program or intentions to participate
across the three framing conditions suggest that concerns about
framing effects in this context may be unwarranted.
Our ﬁndings complement prior work that has consistently
found that individual’s understanding and beliefs related to the
concepts of equipoise and randomization may be determinants of
engagement in research. More speciﬁcally, patients’ have been
found to have signiﬁcant difﬁculty understanding the concept of
equipoise (Mills et al., 2003) and to have difﬁculty believing that
their provider may not be sure of the best option (Robinson et al.,
2004). Similarly patients’ often fail to understand the idea of
randomization to treatment (Falagas, Korbila, Giannopoulou,
Kondilis, & Peppas, 2009), and even when they understand the
concept, they often disagree that randomization to treatment is
appropriate if the provider does not know which treatment is best
(Robinson et al., 2005). This study adds to this prior literature byidentifying speciﬁc beliefs that may drive engagement in prag-
matic clinical research.
The relationship between intention to participate in POC-R and
willingness to complete a blanket consent points to the difﬁculties
to be addressed as comparative effectiveness research programs
are implemented on a large scale. The Ofﬁce for Human Research
Protections (OHRP) has recently proposed a draft policy to guide
researchers in rules for consenting patients in comparative effec-
tive studies where both arms reﬂect accepted standards of care
(equipoise). They argue that those risks under evaluation that
would be different for some patients must be communicated to
participating patients. Recently the editors of the New England
Journal of Medicine argued that the OHRP draft policy be revised
to reﬂect the fact that the very purpose of pragmatic trials is to
determine if an actual differential effect exists, in situations in
which no difference is currently known (Editors, November 27,
2014; OHRP, 2015) Others have argued that when comparing two
accepted standards of care, describing them in terms of risks and
potential harm makes the research seem more risky than it is and
therefore make the consent process more complicated (Lantos &
Spertus, 2014, November 27, 2014). Regardless of the outcome of
the debate on the presentation of risks in consent for pragmatic
research, health systems that seek to implement pragmatic trials
on a systematic basis will need to determine whether to imple-
ment a blanket or periodic consent procedure. This decision may
increase the complexity of communicating with patients (Falagas
et al., 2009), and, as our results suggest, may impact enrollment.
Strengths
The primary strength of this study is the randomized design. In
addition, the measurement instrument was grounded in prior
qualitative work, thereby improving generalizability. In addition,
many patients in this study had experience participating in
research thus allowing them to base their responses on prior
experience rather than on a purely hypothetical scenario.
Limitations
This study has limitations that should be addressed in future
work. Although we piloted the items in the survey, it is possible
that patients may not have understood the differing frames of the
purpose of POC-R and this may have affected our results. The
instrument itself was not a fully developed validated tool. How-
ever, the high levels of reliability in the created scales and the fact
that the items were derived from prior qualitative work enhance
the validity of measurement. In addition since this study was
conducted with a veteran population it is possible that our ﬁnd-
ings may not generalize to other groups, therefore this study
should be replicated with other populations. Finally, our correla-
tional data does not provide causal proof regarding the relation-
ship between attitudes and intentions and behavior.
Future work
Future work could focus on improving the content validity of
the survey instrument, In addition, more work is needed to clarify
the relationship between how patients understand randomization,
equipoise, and differing consent models and their beliefs and
attitude towards pragmatic research. Finally it is likely that indi-
viduals’ beliefs may change as awareness of pragmatic research
increases so that the focus of patient’s concerns may be different
in the future.
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In conclusion, patients appeared to have a generally positive
attitude toward pragmatic trials, with those believing that parti-
cipating in research is a duty and that research can improve care
being more likely to participate. No evidence was found that dif-
ferences in framing of the purposes of the research made a dif-
ference in attitudes or in willingness to participate.Conﬂict of interest
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